References
- DiSaia PJ, Saltz A, Kagan AR, Morrow CP. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol 1977;49:346-350
- Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. Cancer 1982;50:1629-1635 https://doi.org/10.1002/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1
- Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, et al. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019;17:1529-1554 https://doi.org/10.6004/jnccn.2019.0058
- Steyerberg EW, Keizer HJ, Fossa SD, Sleijfer DT, Toner GC, Schraffordt Koops H, et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13:1177-1187 https://doi.org/10.1200/JCO.1995.13.5.1177
- Daneshmand S, Albers P, Fossa SD, Heidenreich A, Kollmannsberger C, Krege S, et al. Contemporary management of postchemotherapy testis cancer. Eur Urol 2012;62:867-876 https://doi.org/10.1016/j.eururo.2012.08.014
- Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003;21:3310-3317 https://doi.org/10.1200/JCO.2003.03.184
- Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour. BJU Int 2007;99:993-997 https://doi.org/10.1111/j.1464-410X.2007.06740.x
- Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 2007;25:1033-1037 https://doi.org/10.1200/JCO.2005.05.4791
- Maroto P, Tabernero JM, Villavicencio H, Mesia R, Marcuello E, Sole-Balcells FJ, et al. Growing teratoma syndrome: experience of a single institution. Eur Urol 1997;32:305-309 https://doi.org/10.1159/000480830
- Paffenholz P, Pfister D, Matveev V, Heidenreich A. Diagnosis and management of the growing teratoma syndrome: a single-center experience and review of the literature. Urol Oncol 2018;36:529.e23-529.e30
- Kikawa S, Todo Y, Minobe S, Yamashiro K, Kato H, Sakuragi N. Growing teratoma syndrome of the ovary: a case report with FDG-PET findings. J Obstet Gynaecol Res 2011;37:926-932 https://doi.org/10.1111/j.1447-0756.2010.01439.x
- Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 1998;82:1343-1351 https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1343::AID-CNCR18>3.0.CO;2-6
- van der Gaast A, Kok TC, Splinter TA. Growing teratoma syndrome successfully treated with lymphoblastoid interferon. Eur Urol 1991;19:257-258 https://doi.org/10.1159/000473633
- Andre F, Fizazi K, Culine S, Droz J, Taupin P, Lhomme C, et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 2000;36:1389-1394 https://doi.org/10.1016/S0959-8049(00)00137-4
- Chen LT, Chen CL, Hwang WS. The growing teratoma syndrome. A case of primary mediastinal nonseminomatous germ cell tumor treated with chemotherapy and radiotherapy. Chest 1990;98:231-233 https://doi.org/10.1378/chest.98.1.231
- Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med 2007;131:1267-1280 https://doi.org/10.5858/2007-131-1267-AOOTGC
- Inaoka T, Takahashi K, Yamada T, Miyokawa N, Tokusashi Y, Yoshida M, et al. The growing teratoma syndrome secondary to immature teratoma of the ovary. Eur Radiol 2003;13:2115-2118 https://doi.org/10.1007/s00330-002-1733-3
- Umekawa T, Tabata T, Tanida K, Yoshimura K, Sagawa N. Growing teratoma syndrome as an unusual cause of gliomatosis peritonei: a case report. Gynecol Oncol 2005;99:761-763
- Stomper PC, Kalish LA, Garnick MB, Richie JP, Kantoff PW. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology 1991;180:711-714 https://doi.org/10.1148/radiology.180.3.1651526
- Panicek DM, Toner GC, Heelan RT, Bosl GJ. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy. Radiology 1990;175:499-502 https://doi.org/10.1148/radiology.175.2.2158120
- Miranda Ede P, Abe DK, Nesrallah AJ, dos Reis ST, Crippa A, Srougi M, et al. Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study. World J Surg Oncol 2012;10:203
- Kattan J, Droz JP, Culine S, Duvillard P, Thiellet A, Peillon C. The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary. Gynecol Oncol 1993;49:395-399
- Han NY, Sung DJ, Park BJ, Kim MJ, Cho SB, Kim KA, et al. Imaging features of growing teratoma syndrome following a malignant ovarian germ cell tumor. J Comput Assist Tomogr 2014;38:551-557 https://doi.org/10.1097/RCT.0000000000000073
- Pfannenberg AC, Oechsle K, Bokemeyer C, Kollmannsberger C, Dohmen BM, Bares R, et al. The role of [18F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management. World J Urol 2004;22:132-139
- Aide N, Comoz F, Sevin E. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence? J Clin Oncol 2007;25:4494-4496 https://doi.org/10.1200/JCO.2007.12.7530
- Coscojuela P, Llauger J, Perez C, Germa J, Castaner E. The growing teratoma syndrome: radiologic findings in four cases. Eur J Radiol 1991;12:138-140 https://doi.org/10.1016/0720-048X(91)90116-D
- Lorigan JG, Eftekhari F, David CL, Shirkhoda A. The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis. AJR Am J Roentgenol 1988;151:325-329 https://doi.org/10.2214/ajr.151.2.325
- Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, et al. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol 2007;177:1330-1334
- Lee DJ, Djaladat H, Tadros NN, Movassaghi M, Tejura T, Duddalwar V, et al. Growing teratoma syndrome: clinical and radiographic characteristics. Int J Urol 2014;21:905-908 https://doi.org/10.1111/iju.12466
- Jeffery GM, Theaker JM, Lee AH, Blaquiere RM, Smart CJ, Mead GM. The growing teratoma syndrome. Br J Urol 1991;67:195-202 https://doi.org/10.1111/j.1464-410X.1991.tb15109.x